Search Results - sars-cov-2

PubPharm (1.714)

1

Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19

in: BMC infectious diseases | 2024

by Camp, D. | Caputo, M. | Echevarria, F. | +1

2

Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial

in: BMC infectious diseases | 2024

by Zhao, H. | Meng, W. | Lv, X. | +9

3

Longevity of hybrid immunity against SARS-CoV-2 in adults vaccinated with an adenovirus-based COVID-19 vaccine

in: BMC infectious diseases | 2024

by Mvula, M. | Mtonga, F. | Mandolo, J. | +7

4

Assessing exit screening of SARS-CoV-2 in Japan: an analysis of the airport screening data of passengers from the United Kingdom, 2020–2022

in: BMC infectious diseases | 2024

by Liu, S. | Anzai, A. | Nishiura, H.

5

A two-variant model of SARS-COV-2 transmission : estimating the characteristics of a newly emerging strain

in: BMC infectious diseases | 2024

by Yamana, T. | Rajagopal, S. | Hall, D. | +11

6

A two-variant model of SARS-COV-2 transmission: estimating the characteristics of a newly emerging strain

in: BMC infectious diseases | 2024

by Yamana, T. | Rajagopal, S. | Hall, D. | +11

7

Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2

in: BMC infectious diseases | 2024

by Degtiarova, G. | Conen, A. | Klarer, A. | +5

8

Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2

in: BMC infectious diseases | 2024

by Degtiarova, G. | Conen, A. | Klarer, A. | +5

9

Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19 : a retrospective single center study

in: BMC infectious diseases | 2024

by Park, S. | Je, N. | Kim, D. | +2

10

Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study

in: BMC infectious diseases | 2024

by Park, S. | Je, N. | Kim, D. | +2

1
2
3
4
5
6
7
8
9
10
11
Next »
[172]